Florian Eichler

Director, Center for Rare Neurological Diseases · Mass General Brigham

Credentials: · · · ·

History

Global Leukodystrophy Initiative Clinical Trials Network (GLIA- CTN)
National Institute of Neurological Disorders and Stroke · U54
PI · $12.8M · Children's Hosp of Philadelphia
2019–2030
Phase 2 Study of L-Serine in HSN Type 1
Food and Drug Administration · R01
Contact PI · $1.6M · Massachusetts General Hospital
2012–2018
Safety, Tolerability and Biological Activity of L-Serine in HSAN1.
National Institute of Neurological Disorders and Stroke · R01
Contact PI · $410.6K · Massachusetts General Hospital
2013–2017
The Role of Desoxysphingoid Bases in HSAN1
National Institute of Neurological Disorders and Stroke · R01
Contact PI · $2.1M · Massachusetts General Hospital
2011–2016

Single Participant Study of an Experimental ASO Treatment for TUBB4A-related Leukodystrophy
Principal investigator · Enrolling by invitation · Phase 1, Phase 2
Massachusetts General Hospital
2024–2026
Treating Leg Symptoms in Women With X-linked Adrenoleukodystrophy
Principal investigator · Active not recruiting · Phase 4
Massachusetts General Hospital
2023–2026
A Natural History Study of Canavan Disease
Principal investigator · Completed
NYU Langone Health
2016–2019
A Natural History of Late Onset Tay-Sachs Disease
Principal investigator · Completed
Massachusetts General Hospital
2016–2025